A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells

Knutson, Sarah K, Wigle, Tim J, Warholic, Natalie M, Sneeringer, Christopher J, Allain, Christina J, Klaus, Christine R, Sacks, Joelle D, Raimondi, Alejandra, Majer, Christina R, Song, Jeffrey, Scott, Margaret Porter, Jin, Lei, Smith, Jesse J, Olhava, Edward J, Chesworth, Richard, Moyer, Mikel P, Richon, Victoria M, Copeland, Robert A, Keilhack, Heike, Pollock, Roy M, Kuntz, Kevin W·2012·Nature Chemical Biology
DOI 10.1038/nchembio.1084

Cited by (807)

Items 801–807 of 807

  1. BindingDB Entry 50049189: Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer Efficacy.
    BindingDB · 2019 · UC San Diego
  2. BindingDB Entry 50047123: The Importance of Being Me: Magic Methyls, Methyltransferase Inhibitors, and the Discovery of Tazemetostat.
    BindingDB · 2017 · UC San Diego
  3. BindingDB Entry 50042555: Exploiting an allosteric binding site of PRMT3 yields potent and selective inhibitors.
    BindingDB · 2013 · UC San Diego
  4. BindingDB Entry 50015988: Histone Deacetylase and Enhancer of Zeste Homologue 2 Dual Inhibitors Presenting a Synergistic Effect for the Treatment of Hematological Malignancies.
    BindingDB · 2023 · UC San Diego
  5. BindingDB Entry 50010226: Structure-Activity Relationship Studies for Enhancer of Zeste Homologue 2 (EZH2) and Enhancer of Zeste Homologue 1 (EZH1) Inhibitors.
    BindingDB · 2021 · UC San Diego
  6. BindingDB Entry 50001605: Discovery of EBI-2511: A Highly Potent and Orally Active EZH2 Inhibitor for the Treatment of Non-Hodgkin's Lymphoma.
    BindingDB · 2020 · UC San Diego
  7. BindingDB Entry 7924: An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED.
    BindingDB · 2017 · UC San Diego